학술논문
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Document Type
Article
Author
Source
In Annals of Oncology November 2017 28(11):2820-2826
Subject
Language
ISSN
0923-7534